{"title":"AACR-NCI-EORTC -第33届分子靶点和癌症治疗国际研讨会。虚拟- 2021年10月7日至10日","authors":"E. R. Domenech, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.1.3393251","DOIUrl":null,"url":null,"abstract":"The 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting, organized by the European Organization for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), was held in a virtual format due to the ongoing COVID-19 pandemic. Historically, 1,500 to 2,500 academics, scientists and pharmaceutical industry representatives come together at this meeting to deliver the latest updates on drug discovery, target selection, cellular and molecular biology, and early clinical trials. This year presentations were delivered both live and on-demand in oral and poster sessions. This report highlights some of the important research presented throughout the meeting.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AACR-NCI-EORTC - 33rd International Symposium on Molecular Targets and Cancer Therapeutics. Virtual - October 7-10, 2021\",\"authors\":\"E. R. Domenech, P. Cole, X. Bofill\",\"doi\":\"10.1358/dof.2022.47.1.3393251\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting, organized by the European Organization for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), was held in a virtual format due to the ongoing COVID-19 pandemic. Historically, 1,500 to 2,500 academics, scientists and pharmaceutical industry representatives come together at this meeting to deliver the latest updates on drug discovery, target selection, cellular and molecular biology, and early clinical trials. This year presentations were delivered both live and on-demand in oral and poster sessions. This report highlights some of the important research presented throughout the meeting.\",\"PeriodicalId\":11366,\"journal\":{\"name\":\"Drugs of The Future\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs of The Future\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1358/dof.2022.47.1.3393251\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.1.3393251","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
AACR-NCI-EORTC - 33rd International Symposium on Molecular Targets and Cancer Therapeutics. Virtual - October 7-10, 2021
The 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting, organized by the European Organization for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), was held in a virtual format due to the ongoing COVID-19 pandemic. Historically, 1,500 to 2,500 academics, scientists and pharmaceutical industry representatives come together at this meeting to deliver the latest updates on drug discovery, target selection, cellular and molecular biology, and early clinical trials. This year presentations were delivered both live and on-demand in oral and poster sessions. This report highlights some of the important research presented throughout the meeting.
期刊介绍：
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.
The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
